Literature DB >> 27389998

Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis.

Fiona Maas1, Anneke Spoorenberg2, Boukje P G van der Slik1, Eveline van der Veer1, Elisabeth Brouwer1, Hendrika Bootsma1, Reinhard Bos3, Freke R Wink3, Suzanne Arends2.   

Abstract

INTRODUCTION: To investigate the prevalence and incidence of radiographic vertebral fractures and the association with patient characteristics, clinical assessments, and medication use in a large prospective cohort of patients with ankylosing spondylitis (AS) in daily clinical practice.
METHODS: Consecutive AS patients from the Groningen Leeuwarden AS (GLAS) cohort with baseline and 2-year lateral radiographs of the thoracic and lumbar spine were included. Radiographs were scored for vertebral fractures by 2 readers according to the method of Genant et al. Differences in baseline characteristics between patients with and without radiographic vertebral fractures were explored.
RESULTS: Of 292 included AS patients, 59 (20%) had radiographic vertebral fractures at baseline, 15 (6%) developed new fractures, and 7 (2%) showed an increase in the severity of existing fractures during 2 years of follow-up. Most fractures were mild and located in the midthoracic and thoracolumbar region of the spine. The presence of vertebral fractures was significantly associated with older age, higher body mass index, longer smoking duration, larger occiput-to-wall distance, more spinal radiographic damage, and lower hip bone mineral density (BMD). The development of new or progressive vertebral fractures was also associated with older age and low BMD. Patients using nonsteroidal antiinflammatory drugs (NSAIDs) at baseline showed less prevalent and incident vertebral fractures.
CONCLUSION: In this large AS cohort in daily clinical practice, radiographic vertebral fractures were frequently present in AS, especially in older patients with more advanced disease, low hip BMD, and a less healthy lifestyle. Interestingly, NSAID use was associated with a reduced vertebral fractures risk.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 27389998     DOI: 10.1002/acr.22980

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  12 in total

1.  Service discharges among US Army personnel with selected musculoskeletal and skin conditions: a retrospective cohort study.

Authors:  D Alan Nelson; Robert M Kaplan; Michael H Weisman; Lianne M Kurina
Journal:  BMJ Open       Date:  2022-10-14       Impact factor: 3.006

Review 2.  [Becoming older with axial spondyloarthritis].

Authors:  U Kiltz; X Baraliakos; B Buehring; J Braun
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

3.  Treatment of kyphosis in ankylosing spondylitis by osteotomy through the gap of a pathological fracture: a retrospective study.

Authors:  Hongqi Zhang; Zhenhai Zhou; Chaofeng Guo; Yuxiang Wang; Honggui Yu; Longjie Wang
Journal:  J Orthop Surg Res       Date:  2016-11-08       Impact factor: 2.359

4.  Comorbidity, disability, and healthcare expenditure of ankylosing spondylitis in Korea: A population-based study.

Authors:  Jeong Seok Lee; Baek-Lok Oh; Hee Young Lee; Yeong Wook Song; Eun Young Lee
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 5.  Osteoporosis in Rheumatic Diseases.

Authors:  Giovanni Adami; Angelo Fassio; Maurizio Rossini; Cristian Caimmi; Alessandro Giollo; Giovanni Orsolini; Ombretta Viapiana; Davide Gatti
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

6.  Distribution of comorbidities in spondyloarthritis with regard to the phenotype and psoriasis: data from the ASAS-COMOSPA study.

Authors:  M Ángeles Puche-Larrubia; Lourdes Ladehesa-Pineda; Pilar Font-Ugalde; Alejandro Escudero-Contreras; Anna Moltó; Clementina López-Medina; Eduardo Collantes-Estévez
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-09-20       Impact factor: 5.346

Review 7.  Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  Maud Wieczorek; James Martin Gwinnutt; Maxime Ransay-Colle; Suzanne Mm Verstappen; Francis Guillemin; Andra Balanescu; Heike Bischoff-Ferrari; Annelies Boonen; Giulio Cavalli; Savia de Souza; Annette de Thurah; Thomas Ernst Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja A Stamm; Karen Walker-Bone; Joep Welling; Mirjana Zlatkovic-Svenda
Journal:  RMD Open       Date:  2022-03

Review 8.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03

9.  Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.

Authors:  Anna Deminger; Eva Klingberg; Mattias Lorentzon; Mats Geijer; Jan Göthlin; Martin Hedberg; Eva Rehnberg; Hans Carlsten; Lennart T Jacobsson; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2017-12-08       Impact factor: 5.156

Review 10.  Comorbidity management in spondyloarthritis.

Authors:  Clementina López-Medina; Anna Molto
Journal:  RMD Open       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.